Litcius/Paper detail

Cancer Associated Fibroblasts - An Impediment to Effective Anti-Cancer T Cell Immunity

Lilian Koppensteiner, Layla Mathieson, Richard A. O’Connor, Ahsan R. Akram

2022Frontiers in Immunology61 citationsDOIOpen Access PDF

Abstract

The presence of functionally efficient cytotoxic T lymphocytes (CTL) in the Tumour nest is crucial in mediating a successful immune response to cancer. The detection and elimination of cancer cells by CTL can be impaired by cancer-mediated immune evasion. In recent years, it has become increasingly clear that not only neoplastic cells themselves, but also cells of the tumour microenvironment (TME) exert immunosuppressive functions and thereby play an integral part in the immune escape of cancer. The most abundant stromal cells of the TME, cancer associated fibroblasts (CAFs), promote tumour progression via multiple pathways and play a role in dampening the immune response to cancer. Recent research indicates that T cells react to CAF signalling and establish bidirectional crosstalk that plays a significant role in the tumour immune response. This review discusses the various mechanisms by which the CAF/T cell crosstalk may impede anti-cancer immunity.

Topics & Concepts

CancerImmunityMedicineCancer researchImmunologyImmune systemInternal medicineImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersCAR-T cell therapy research
Cancer Associated Fibroblasts - An Impediment to Effective Anti-Cancer T Cell Immunity | Litcius